Product Candidates
Aversion® Development Pipeline
Immediate Release Development Candidates
King has licensed in the U.S., Canada, and Mexico Acurox, Acuracet, Vycavert and the 4th opioid and has an option to license all future opioid product candidates, except the 5th undisclosed opioid candidate. The benzodiazepine product candidate is unpartnered.
